AXT, Inc. (AXTI) is a Fremont, California-based materials company that produces compound semiconductor substrates — chiefly indium phosphide, gallium arsenide and germanium — used in the lasers and photodetectors behind AI data-center optical links. In early trading on November 18, the shares stood at $35.55, a decline of 2.39% from the prior session's close of $36.42. The direction was clearly negative, and the stock traded as low as $34.08 before trimming losses. No new press release, filing or guidance update accompanied the move; the decline instead extended a post-earnings de-rating that has been reinforced by cautious analyst commentary and fresh U.S.–China technology-policy headlines.
The most concrete identifiable driver is the analyst reset published ahead of the session. B. Riley lowered its price target on AXTI to $43 from $56 while maintaining a Neutral rating, explicitly tying the revision to the possibility that Beijing slows export permits if Washington tightens chip rules. That matters because every indium phosphide substrate AXT sells is produced in China by its Tongmei subsidiary, and each overseas shipment requires a Chinese permit. Management has said approval flow has improved markedly since indium phosphide was added to China's export-control list in February 2025, but the new target assumes a lower multiple on forward revenue, which resets the valuation anchor for the shares.
Washington's decision to move ahead with restrictions on Chinese optical and data-center equipment cut two ways for this group. It is a tailwind for U.S. transceiver makers displacing Chinese rivals, but it raises the odds of retaliation against China-based suppliers — exactly the scenario B. Riley flagged. The related risk is customer substitution: if permits slow, large buyers could qualify non-Chinese wafer sources, and the resulting share loss would not be quickly recoverable given the multi-year qualification cycles in this industry.
The most notable feature of the session was the split tape. Nvidia's results and roughly $130 billion revenue outlook revived AI hardware demand expectations, and COHR and LITE each climbed about 4%, with Ciena and Marvell also higher. AXT did not participate. That divergence is consistent with stock-specific overhangs — export-permit risk, a Tongmei private financing that carries an 8% annual redemption feature if no qualifying Hong Kong listing occurs within three years, and a valuation that still screens rich relative to the semiconductor group after a parabolic 2026 advance.
Volume was running ahead of the normal pace, with more than 1.4 million shares changing hands in the first twenty minutes against a full-day average near 9.9 million. The broader tape was mixed after the S&P 500 fell about 1% and the Nasdaq touched a seven-month low in the prior session. Technically, the stock remains deeply below its 20-day and 60-day moving averages and roughly 75% under its 52-week high of $143.16, having broken the $40 shelf earlier in the week. With about 21% of shares outstanding sold short, sharp counter-trend rallies remain a recurring feature of the trading pattern.
The scale runs from 0, meaning no meaningful news and a move that is normal for the stock, to 100, meaning transformative news and an extreme, rare price move. This event scores 22 out of 100. The verified news was moderate: a price-target cut and widened policy commentary, material for sentiment but not for near-term cash flows, against a company now worth roughly $2.3 billion. The move was notably unremarkable by the stock's own standards — 2.39% is about one-third of its 6.6% average absolute daily change over the last 60 sessions, and 51 of those sessions produced an equal or larger move. Weak news plus a routine swing produces the low score.
Attention now shifts to the December 20 deadline for the minimum closing of the Tongmei equity financing, a milestone that also governs progress toward a Hong Kong listing. Fourth-quarter guidance of roughly $90 million in revenue, more than 60% gross margin and $0.57-$0.59 in non-GAAP earnings per share sets a demanding bar for the next report. Investors will also track Chinese permit approvals for U.S. customers, any expansion of U.S. import restrictions and the resulting retaliation risk, and the pace of the company's 2027 capacity doubling. Risks are concentrated in the concentration of manufacturing in China, customer qualification of alternative suppliers, dilution terms on the subsidiary financing, and the stock's sensitivity to AI-infrastructure sentiment.
Tickeron's Trending AI Robots page curates the strongest-performing automated strategies from a library of hundreds of AI trading bots that cover thousands of tickers. Because bots differ widely in approach, holding period, performance metrics and the symbols they trade, the featured list changes as market conditions shift. Readers looking for systematic ways to follow volatility like AXTI's can review the current leaders and compare track records before deciding what fits their approach.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The 50-day moving average for AXTI moved below the 200-day moving average on November 04, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
The Momentum Indicator moved below the 0 level on November 02, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AXTI as a result. In 65 of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 81%.
The Moving Average Convergence Divergence Histogram (MACD) for AXTI turned negative on October 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 33 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 73%.
The 10-day moving average for AXTI crossed bearishly below the 50-day moving average on October 16, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 87%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AXTI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
The Aroon Indicator for AXTI entered a downward trend on November 18, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where AXTI's RSI Oscillator exited the oversold zone, 29 of 33 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 88%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
Following a +16.86% 3-day Advance, the price is estimated to grow further. Considering data from situations where AXTI advanced for three days, in 217 of 275 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
AXTI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating steady price growth. AXTI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 75 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 80 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AXTI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock worse than average.
The Tickeron SMR rating for this company is 90 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 98 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.885) is normal, around the industry mean (5.670). AXTI's P/E Ratio (1296.000) is considerably higher than the industry average of (68.795). AXTI's Projected Growth (PEG Ratio) (0.100) is slightly lower than the industry average of (0.801). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (26.596) is also within normal values, averaging (27.897).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufactures of high-performance compound semiconductor substrates
Industry ElectronicProductionEquipment